KMID : 0362919910090020277
|
|
Journal of the Korean Society for Therapeutic Radiology and Oncology 1991 Volume.9 No. 2 p.277 ~ p.284
|
|
Adenocarcinoma of the Uterine Cervix
|
|
Chung Eun-Ji
Shin Hyun-Soo Lee Hyung-Sik Kim Gwi-Eon Loh Juhn-Kyu Suh Chang-Ok
|
|
Abstract
|
|
|
Survival data, prognostic factors, and patterns of failure were retrospectively analyzed for a total of 76 patients with adenocarcinoma of the uterine cervix treated between January 1981 and December 1987, which represents 4.1% of all primary cervical carcinomas treated, at Department of Radiation Oncology, Yensei Cancer Center, Yonsei University College of Medicine. The mean age of the patients was 49years(range, 27~79years) and the peak incidence was in the group 50 to 59years of age. More half of the patients were postmenopausal (46/76=60.5%). Most patients(76%)had abnormal vaginal bleeding either alone or in combination with other symptoms. The proportion of stage Iib was 43.4%. There were 4 major histologic subtypes: pure adenocarcinoma(48/76=63.2%), adenosquamous carcinoma(20/76=26.3%), papillary (5/76=6.6%) and clear cell carcinoma(3/76=3.9%). Of the many clinicopathologic variables evaluated for prognosis, the most significant prognostic factors were stage of disease and the size of tumor. The overall 5-year survival rate was 68%, and the 5-year survival rates for stage Ib, II and III were 90%, 66% and 54%, respectively. Control of pelvic tumors was achieved in 938%, 90.2% and 50.0% of cases of stage Ib, II and III disease, respectively. In present study, treatment modalities (radiation therapy alone/combined operative and radiation therapy) did not affect the local control of tumor and the survival.
|
|
KEYWORD
|
|
Adenocarcinoma of cervix, Tumor size, Stage of the disease
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|